📰 Zai Lab News
Page 46 - Zai Lab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Zai Lab. Real-time updates on events, politics, business and more.
November 14, 2022
/PRNewswire/ -- DelveInsights PD-1 and PD-L1 Inhibitors Competitive Landscape – 2022 report provides comprehensive global coverage of available, marketed,...
November 14, 2022
U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains i...
November 14, 2022
PD-1 and PD-L1 inhibitors clinical trial pipeline constitutes 180+ key companies continuously working towards developing 200+ PD-1 and PD-L1 inhibitors drugs, analyzes DelveInsight LAS
November 9, 2022
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced the appointment of Alan Sandler, M.D., to...
November 9, 2022
Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer - read this article along with other careers information, tips and advice on BioSpace
November 8, 2022
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter of...
November 8, 2022
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced the appointment of Alan Sandler, M.D., to...
November 8, 2022
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter of...
November 4, 2022
The three-day summit, Vision 2045, will take place in Sharm El Sheikh
November 3, 2022
Deadline: 24-Nov-22 Join the second edition of “Tech for Sustainability Campaign 2023” a global initiative to solve real-world sustainability challenges